Skip to the page

Data / Drug companies / Mylan Institutional Inc.

Mylan Institutional Inc.: 91 products in the FDA NDC directory, labeler code 51079

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Mylan Institutional Inc. (labeler code 51079) lists 91 products in the FDA National Drug Code Directory, covering 40 finished drugs by generic name. By type: 88 prescription drugs, 3 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on June 1, 2022.

The request: Watch Mylan Institutional Inc. (FDA labeler code 51079): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
51079
Products in commercial distribution
91
Packages
91
Finished drugs by generic name
40
Prescription products
88
Over the counter products
3
Controlled substance products
Schedule IV 5
Flagged as original packager
1 of 1 products that carry the flag
Started marketing in the last 12 months
0
Products with a marketing end date set
1
Earliest marketing start
May 3, 1994
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)91100%

Products by type

TypeProductsShare
Prescription drugs8896.7%
Over the counter drugs33.3%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet3841.8%
Tablet, film coated2830.8%
Capsule1314.3%
Capsule, extended release44.4%
Tablet, film coated, extended release22.2%
Tablet, extended release22.2%
Powder, for solution11.1%
Tablet, delayed release11.1%
Capsule, delayed release pellets11.1%
Tablet, orally disintegrating11.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Chlordiazepoxide Hydrochloride51079-141CapsuleGeneric drugs (ANDA)June 1, 2022
Chlordiazepoxide Hydrochloride51079-375CapsuleGeneric drugs (ANDA)May 26, 2022
Clozapine51079-288Tablet, orally disintegratingGeneric drugs (ANDA)September 26, 2016
Atorvastatin Calcium51079-208Tablet, film coatedGeneric drugs (ANDA)January 30, 2014
Atorvastatin Calcium51079-210Tablet, film coatedGeneric drugs (ANDA)January 29, 2014
Atorvastatin Calcium51079-209Tablet, film coatedGeneric drugs (ANDA)January 29, 2014
Atorvastatin Calcium51079-211Tablet, film coatedGeneric drugs (ANDA)January 23, 2014
Metoclopramide51079-888TabletGeneric drugs (ANDA)January 2, 2014
Metoclopramide51079-886TabletGeneric drugs (ANDA)December 30, 2013
Sucralfate51079-753TabletGeneric drugs (ANDA)September 24, 2013
Fenofibrate51079-608Tablet, film coatedGeneric drugs (ANDA)June 10, 2013
Fenofibrate51079-599Tablet, film coatedGeneric drugs (ANDA)June 10, 2013
Loratadine51079-246TabletGeneric drugs (ANDA)April 30, 2013
Abacavir Sulfate51079-204Tablet, film coatedGeneric drugs (ANDA)August 1, 2012
Cetirizine Hydrochloride51079-597Tablet, film coatedGeneric drugs (ANDA)March 30, 2012
Voriconazole51079-165Tablet, film coatedGeneric drugs (ANDA)August 8, 2011
Voriconazole51079-164Tablet, film coatedGeneric drugs (ANDA)August 8, 2011
Valacyclovir Hydrochloride51079-093Tablet, film coatedGeneric drugs (ANDA)March 7, 2011
Pantoprazole Sodium51079-051Tablet, delayed releaseGeneric drugs (ANDA)February 23, 2011
Tacrolimus51079-817CapsuleGeneric drugs (ANDA)November 15, 2010
Tacrolimus51079-818CapsuleGeneric drugs (ANDA)November 1, 2010
Tacrolimus51079-028CapsuleGeneric drugs (ANDA)November 1, 2010
Clozapine51079-749TabletGeneric drugs (ANDA)July 6, 2010
Lansoprazole51079-121Capsule, delayed release pelletsGeneric drugs (ANDA)December 1, 2009
Polyethylene Glycol (3350)51079-306Powder, for solutionGeneric drugs (ANDA)October 12, 2009

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.